DocGo Inc.
General ticker "DCGO" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $254.5M (TTM average)
DocGo Inc. does not follow the US Stock Market performance with the rate: -10.8%.
Estimated limits based on current volatility of 3.3%: low 1.01$, high 1.08$
Factors to consider:
- Total employees count: 4407 (+5.8%) as of 2024
- US accounted for 90.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Market competition, Regulatory and compliance, Labor/talent shortage/retention, Operational and conduct risks
- Current price 60.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.63$, 4.63$]
- 2025-12-31 to 2026-12-31 estimated range: [2.62$, 4.61$]
Financial Metrics affecting the DCGO estimates:
- Positive: with PPE of 16.7 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 4.65
- Positive: Operating cash flow per share per price, % of 15.86 > 13.24
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.85
- Negative: Shareholder equity ratio, % of 70.44 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry operating profit margin (median), % of -3.16 <= 2.97
Short-term DCGO quotes
Long-term DCGO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $440.52MM | $624.29MM | $616.56MM |
| Operating Expenses | $418.68MM | $609.23MM | $587.87MM |
| Operating Income | $21.83MM | $15.05MM | $28.69MM |
| Non-Operating Income | $0.95MM | $1.24MM | $-0.94MM |
| Interest Expense | $0.00MM | $0.00MM | $2.17MM |
| R&D Expense | $5.38MM | $10.86MM | $11.59MM |
| Income(Loss) | $22.78MM | $16.29MM | $27.75MM |
| Taxes | $-7.96MM | $6.24MM | $14.39MM |
| Profit(Loss)* | $34.58MM | $6.86MM | $19.99MM |
| Stockholders Equity | $273.23MM | $300.79MM | $320.92MM |
| Inventory | $4.48MM | $0.00MM | $0.00MM |
| Assets | $393.28MM | $490.45MM | $455.62MM |
| Operating Cash Flow | $28.87MM | $-64.22MM | $70.34MM |
| Capital expenditure | $5.50MM | $10.13MM | $5.84MM |
| Investing Cash Flow | $-38.45MM | $-29.88MM | $-10.87MM |
| Financing Cash Flow | $-6.18MM | $1.12MM | $-24.15MM |
| Earnings Per Share** | $0.34 | $0.07 | $0.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.